ShunSin Technology Holdings Limited (6451.TW)
TWD 162.5
(6.56%)
TWD 162.5
(6.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.86 Billion | 621.18 Million | 204.72 Million | 1.88 Billion | 1.93 Billion | -149.73 Million |
| Net Income | 566.65 Million | 16.48 Million | 206.17 Million | 1 Billion | 788.43 Million | 338.41 Million |
| Depreciation & Amortization | 493.72 Million | 512.15 Million | 510.64 Million | 495.05 Million | 592.53 Million | 326.79 Million |
| Deferred income taxes | -224.05 Million | - | 166.52 Million | 172.05 Million | 149.75 Million | 173.13 Million |
| Stock-based compensation | 111.58 Million | 19.32 Million | 39.33 Million | 3.17 Million | 28.47 Million | 25.23 Million |
| Change in working capital | 930.23 Million | 137.05 Million | -579.1 Million | 321.64 Million | 436.49 Million | -897.07 Million |
| Other non-cash items | -13.57 Million | -63.82 Million | -138.85 Million | -109.11 Million | -62.87 Million | -116.23 Million |
| Investing Cash Flow | -823.35 Million | -1.88 Billion | -684.31 Million | -487.52 Million | -1.7 Billion | -1.35 Billion |
| Investments in PPE | -868.62 Million | -1.88 Billion | -1.11 Billion | -440.3 Million | -1.16 Billion | -1.36 Billion |
| Acquisitions | -501 Thousand | 244 Million | 741.35 Million | 26.61 Million | 32.43 Million | 11.05 Million |
| Investment purchases | -13.13 Million | -8.81 Million | -52.57 Million | -72.09 Million | -571.51 Million | - |
| Sales/Maturities of investments | 64.03 Million | -244 Million | -741.35 Million | -26.61 Million | -32.43 Million | - |
| Other Investing Activities | -5.12 Million | 15.84 Million | 481.37 Million | 24.87 Million | 31.66 Million | 8.22 Million |
| Financing Cash Flow | -1.6 Billion | 801.75 Million | -381.66 Million | 2.06 Billion | 1.09 Billion | 558.98 Million |
| Debt repayment | -1.93 Billion | -8.16 Billion | -8.16 Billion | -5.55 Billion | -5.65 Billion | -4.27 Billion |
| Dividends payments | -123.58 Million | -275.11 Million | -440.21 Million | -387.64 Million | -239.36 Million | -99.12 Million |
| Common Stock Repurchased | - | -151.23 Million | 7.86 Billion | 7.86 Billion | -243.43 Million | - |
| Common Stock Issuance | 42.88 Million | - | 93.89 Million | 142.51 Million | 103.07 Million | - |
| Other Financing Activities | 456.37 Million | 9.39 Billion | 264.8 Million | -341 Thousand | 7.13 Billion | 4.93 Billion |
| Accounts receivables | 444.75 Million | -324.64 Million | 200.93 Million | 194.93 Million | 270.96 Million | -920.06 Million |
| Accounts payables | -305.69 Million | 490 Thousand | 307.87 Million | -40.8 Million | -227.23 Million | 93.95 Million |
| Inventory | 432.43 Million | 339.79 Million | -816.25 Million | 8.86 Million | 167.47 Million | -114.99 Million |
| Other working capital | 358.73 Million | 121.4 Million | -271.65 Million | 158.64 Million | 225.28 Million | -782.08 Million |
| Cash at beginning of period | 8.81 Billion | 9.06 Billion | 9.94 Billion | 6.38 Billion | 5.29 Billion | 6.36 Billion |
| Cash at end of period | 8.07 Billion | 8.81 Billion | 9.06 Billion | 9.94 Billion | 6.38 Billion | 5.29 Billion |
| Capital Expenditure | -868.62 Million | -1.88 Billion | -1.11 Billion | -440.3 Million | -1.16 Billion | -1.36 Billion |
| Effect of forex changes on cash | -189.33 Million | 212.51 Million | -15.22 Million | 95.12 Million | -224.93 Million | -128.66 Million |
| Net cash flow / Change in cash | -749.23 Million | -247.16 Million | -876.48 Million | 3.55 Billion | 1.09 Billion | -1.07 Billion |
| Free Cash Flow | 995.94 Million | -1.26 Billion | -908.39 Million | 1.44 Billion | 765.24 Million | -1.5 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 94.57 Million | -105.6 Million | 235.61 Million | 566.65 Million | 183.22 Million | 101.43 Million |
| Depreciation & Amortization | 149.3 Million | 148.11 Million | 138.11 Million | 493.72 Million | 116.6 Million | 120.29 Million |
| Deferred income taxes | - | - | -122.94 Million | -224.05 Million | -31.21 Million | -61.13 Million |
| Stock-based compensation | 14.53 Million | 28.11 Million | 28.69 Million | 111.58 Million | 28.11 Million | 26.44 Million |
| Change in working capital | -295.66 Million | 62.09 Million | 950.93 Million | 930.23 Million | -271.78 Million | 114.24 Million |
| Other non-cash items | 3.84 Million | -4.78 Million | -6.82 Million | -13.57 Million | -430 Thousand | -8.04 Million |
| Investing Cash Flow | -1.39 Billion | -377.08 Million | -211.82 Million | -823.35 Million | -218.97 Million | -259.09 Million |
| Investments in PPE | -252.6 Million | -308.88 Million | -213.78 Million | -868.62 Million | -215.22 Million | -265.37 Million |
| Acquisitions | 166.97 Million | 390 Thousand | 2.95 Million | -501 Thousand | 1.75 Million | -501 Thousand |
| Investment purchases | -1.13 Billion | -70.27 Million | - | -13.13 Million | -1.75 Million | -2.63 Million |
| Sales/Maturities of investments | - | - | - | 64.03 Million | 1.7 Million | 8.61 Million |
| Other Investing Activities | -22 Thousand | 1.68 Million | -992 Thousand | -5.12 Million | -5.45 Million | 795 Thousand |
| Financing Cash Flow | 135.38 Million | -212.64 Million | -162.68 Million | -1.6 Billion | -9.95 Million | -14.76 Million |
| Debt repayment | -15.79 Million | -200.03 Million | -186.09 Million | -1.93 Billion | -73.99 Million | -106.09 Million |
| Dividends payments | - | - | -74.81 Million | -123.58 Million | -48.77 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 42.88 Million | 42.88 Million | - |
| Other Financing Activities | 166.84 Million | -3.73 Million | 98.22 Million | 456.37 Million | 112.81 Million | 91.33 Million |
| Accounts receivables | -316.1 Million | -6.44 Million | 504.33 Million | 444.75 Million | -362.94 Million | 151.52 Million |
| Accounts payables | 244.32 Million | 66.98 Million | -31.47 Million | -305.69 Million | 5.51 Million | -86.2 Million |
| Inventory | -229.05 Million | 3.25 Million | 216.79 Million | 432.43 Million | -46.46 Million | 98.32 Million |
| Other working capital | 5.17 Million | -1.69 Million | 261.27 Million | 358.73 Million | 132.12 Million | -49.4 Million |
| Cash at beginning of period | 7.94 Billion | 8.07 Billion | 7.52 Billion | 8.81 Billion | 7.44 Billion | 7.62 Billion |
| Cash at end of period | 6.61 Billion | 7.94 Billion | 8.07 Billion | 8.07 Billion | 7.52 Billion | 7.44 Billion |
| Capital Expenditure | -252.6 Million | -308.88 Million | -213.78 Million | -868.62 Million | -215.22 Million | -265.37 Million |
| Effect of forex changes on cash | 63.43 Million | 302.44 Million | -306.4 Million | -189.33 Million | 292.16 Million | -207.59 Million |
| Net cash flow / Change in cash | -1.33 Billion | -122.13 Million | 542.68 Million | -749.23 Million | 87.76 Million | -188.19 Million |
| Free Cash Flow | -395.08 Million | -143.73 Million | 1 Billion | 995.94 Million | -190.69 Million | 27.87 Million |
3867
5072
0HF6
ADVENZYMES
0QYE
KOKUYOCMLN